Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Deaths from lung cancer could be reduced by better policies to control indoor radon
Slashdot It! Slashdot Deaths from lung cancer could be reduced by better policies to control indoor radon
Submit to Reddit Submit Deaths from lung cancer could be reduced by better policies to control indoor radon to Reddit
Reading: Deaths from lung cancer could be reduced by better policies to control indoor radonTwitter This Reading: Deaths from lung cancer could be reduced by better policies to control indoor radonTwitter Deaths from lung cancer could be reduced by better policies to control indoor radon
Add to Facebook Add Deaths from lung cancer could be reduced by better policies to control indoor radon to Facebook

Deaths from lung cancer could be reduced by better policies to control indoor radon

January 07, 2009

Research paper: Lung cancer deaths from indoor radon and the cost-effectiveness and potential of policies to reduce them

About 1100 people each year die in the UK from lung cancer related to indoor radon, but current government protection policies focus mainly on the small number of homes with high radon levels and neglect the 95% of radon related deaths caused by lower levels of radon, according to a study published on bmj.com today.




The authors argue that installing basic and cheap measures to prevent radon in all new homes would be more cost-effective and have greater potential for reducing lung cancer deaths caused by radon, and UK Building Regulations should be amended to enforce this.

Radon in the home is a natural air pollutant produced by the decay of uranium in the ground. Radon gas seeps into buildings through cracks and holes in the foundations and when it decays it produces particles that can enter the lungs and expose them to damaging radiation.

At present, government policies in the UK concentrate on searching for homes with high levels of radon and encouraging homeowners to take remedial action at their own expense.

Professor Alastair Gray, Professor Sarah Darby and other colleagues from the University of Oxford, assessed the contribution of indoor radon to lung cancer deaths in the UK, and examined the cost- effectiveness of policies to control radon exposure. They used recent evidence on the risk of lung cancer from indoor radon, based on data from 7,000 people with lung cancer and more than 21,000 people without lung cancer across Europe. They then calculated the lifetime risk of lung cancer death before and after various interventions to control radon, and the costs involved.

The authors estimate that 1100 deaths a year in the UK are related to radon, about 3.3% of all deaths from lung cancer, but less than 5% of radon related deaths occur from exposure above the current action level. In addition, they report that many homeowners refuse to have their home tested or to spend money reducing radon levels. As a result these policies are costly and have a minimal impact on radon related deaths.

In contrast, the authors found that installing simple preventive measures in new homes is highly cost-effective, but at present is only being done in selected areas of the country. This should be rolled out across the whole UK, say the authors, and should be backed up by changes to the Building Regulations. A gas-resistant membrane in the foundations would reduce radon by about 50% and would cost only about £100.

Importantly, the study also found that six out of seven radon related lung cancers occur in people who smoke or who have smoked in the past. The best way for current smokers to reduce risk is to stop smoking. Current and former smokers can also reduce their risk by taking radon control measures seriously, say the authors.

The authors suggest that their findings are relevant to many other countries, most of which have higher concentrations of radon than the UK. The average radon concentration in UK homes is 21 bequerels per cubic metre, but in the European Union the average is 55, suggesting that about 8% of deaths from lung cancer, or 18,000 deaths each year, are caused by radon across the EU.

This is the most extensive and detailed evaluation to date of the policies to counter radon-induced and deaths from lung cancer, say Professor Anssi Auvinen from the University of Tampere in Finland and Professor Göran Pershagen from the Institute of Environmental Medicine in Sweden, in an accompanying editorial.

The findings suggest that:"Radon policies need to be scrutinised [and particularly in populations with low average levels], the priority should be to apply basic measures universally rather than to take action only when high radon levels have been identified by measurement."

BMJ-British Medical Journal





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Dolphins   Schizophrenia   Pulmonary Fibrosis   Amygdala   Tomato   Bone Density   Hearing Loss   Circadian Clock   Blood-brain Barrier   Lifespan   Ozone Layer   Hepatitis   Mosquitoes   Silicon   Drug Resistance   Mitochondrial   Auditory Cortex   Bisphosphonates   Cortisol   Sleep Disorders   Tissue engineering   Parkinson Disease   Erectile dysfunction   Chemotherapy   HPV vaccine  
Related Lung Cancer Current Events and Lung Cancer News Articles Lung Cancer Current Events and Lung Cancer News RSS Lung Cancer Current Events and Lung Cancer News RSS
Researchers find clear difference in quality, type of lung cancer info available in US and Japan
A study published in the July 2009 issue of the Journal of Thoracic Oncology revealed that internet-based lung cancer information was of a higher quality in the United States (US) than in Japan.

Cancer researchers link DICER1 gene mutation to rare childhood cancer
Research published today in Science Express from the journal Science demonstrates the first definitive link between mutations in the gene DICER1 and cancer.

Study finds cancer is the second most frequent cause of death in individuals with schizophrenia
People with schizophrenia die from cancer four times as often as people in the general population.

UCLA cancer researchers develop model that may help identify cancer stem cells
Researchers at UCLA's Jonsson Comprehensive Cancer Center, on a quest to find lung cancer stem cells, have developed a unique model to allow further investigation into the cells that many believe may be at the root of all lung cancers.

Prostate cancer test improves prediction of disease course
A new prostate cancer risk assessment test, developed by a UCSF team, gives patients and their doctors a better way of gauging long-term risks and pinpointing high risk cases.

DKK-3 and WIF-1: Proteins related to liver cancer development?
Liver cancer is one of the most fatal human malignancies and the third most frequent cause of tumor-related death, about half a million people globally each year.

Defeating nicotine's double role in lung cancer
A lung cancer treatment that inhibits nicotine receptors was shown to double survival time in mice, according to Italian researchers.

Vaporized viral vector shows promise in anti-cancer gene therapy
A new lung cancer therapy employing a vaporized viral vector to deliver a cancer-inhibiting molecule directly to lung tissue shows early promise in mouse trials, according to researchers at the Ministry of Education, Science and Technology in Korea.

Common chemotherapy drug triggers fatal allergic reactions
A chemotherapy drug that is supposed to help save cancer patients' lives, instead resulted in life-threatening and sometimes fatal allergic reactions.

Women under-represented in cancer research, U-M study finds
Women are under-represented in clinical cancer research published in high-impact journals, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.
More Lung Cancer Current Events and Lung Cancer News Articles
How to Survive Lung Cancer - A Practical 12-Step Plan

How to Survive Lung Cancer - A Practical 12-Step Plan
by Michael Lloyd (Author)

Written by a lung cancer survivor who understands what it takes to beat the odds, this book offers unparalleled hope and direction for anyone facing this illness. It is filled with specific exercises and techniques to promote healing and reverse side effects by taking a pro-active approach in helping to restore your mind, body and spirit to an optimum state of health. Endorsed by a Lung Cancer Specialist and Associate Professor at Harvard Medical School, this book combines what the doctors tell you with critical information they don't tell you. Visit www.SurviveLungCancer.com for chapter summaries.

Lung Cancer: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages.  What  You Need to Know About Lung Cancer

Lung Cancer: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages. What You Need to Know About Lung Cancer

Lung Cancer Book: What You Need to Know About Lung Cancer... This Lung Cancer Book is for people seeking more information about Lung Cancer, Lung Cancer Treatments, Stages, Signs, and Causes. It is also for family members and others seeking to learn more information on Lung Cancer and gain a better understanding on how to help and support lung cancer patients. This Lung Cancer Book is concise, factual, and to the point. This National Cancer Institute (NCI) booklet is about lung cancer, cancer that begins in the lung. It tells about diagnosis, staging, treatment, and comfort care. Learning about the medical care for people with lung cancer can help you take an active part in making choices about your own care. This booklet has lists of questions that you may want to ask your...

Voices of Lung Cancer: The Healing Companion: Stories for Courage, Comfort and Strength (Voices Of series)

Voices of Lung Cancer: The Healing Companion: Stories for Courage, Comfort and Strength (Voices Of series)
by The Healing Project (Editor), S. Epatha Merkerson (Editor)

Provided by the patients, their friends, families, and caregivers of those diagnaosed with lung cancer, these very personal stories offer inspired insight into the ways families and professionals care for both themselves and the patient, gain a deeper understanding of the relationships, and learn to come to terms with the end of life. Included are essays by medical experts about the science of lung cancer, current treatments, choosing the right doctors, and what the future holds for the next generation of patients.

FlameEz-Lung, 60 Capsules/Bottle

FlameEz-Lung, 60 Capsules/Bottle
by FlameEz

Chronic Obstructive Pulmonary Disease (COPD) is progressive inflammatory disease affecting the respiratory tract and the lungs. Inflammation causes destruction of airways and lung tissues. If inflammation persists, the damage to the airways and lungs may not be reversed. Recent studies also suggest that inflammation is a critical component in lung cancer development, progression and metastasis. Inflammation induces the release of a variety of inflammatory cytokines that cause oxidative damage, DNA mutation, and cell transformation. Inflammation also plays a key role in survival and expansion of tumor cells. Since tumor cells produce various substances that attract inflammatory cells, which are indispensable participants in tissue disruption and metastasis, inflammation has been described...

Mom Lung Cancer Support Kids Light T-Shirt

Mom Lung Cancer Support Kids Light T-Shirt



Non-Small Cell Lung Cancer: New Therapies

Non-Small Cell Lung Cancer: New Therapies



Voices of Lung Cancer: The Healing Companion: Stories for Courage, Comfort and Strength

Voices of Lung Cancer: The Healing Companion: Stories for Courage, Comfort and Strength
by LaChance Publishing LLC

Provided by the patients, their friends, families, and caregivers of those diagnaosed with lung cancer, these very personal stories offer inspired insight into the ways families and professionals care for both themselves and the patient, gain a deeper understanding of the relationships, and learn to come to terms with the end of life. Included are essays by medical experts about the science of lung cancer, current treatments, choosing the right doctors, and what the future holds for the next generation of patients.

Mom Lung Cancer Support Large Mug

Mom Lung Cancer Support Large Mug
by CafePress



Lung Cancer: Myths, Facts, Choices--and Hope

Lung Cancer: Myths, Facts, Choices--and Hope
by Claudia I. Henschke (Author), Peggy McCarthy (Author), Sarah Wernick (Contributor)

Winner of the 2003 American Society of Journalists and Authors' June Roth Memorial Award for Health and Medical Books. An authoritative book with new lifesaving strategies for those at risk and those already diagnosed.

Lung cancer kills more women than breast cancer, more men than prostate cancer—because it's usually found too late. Claudia Henschke's groundbreaking research on early diagnosis, published in The Lancet, made headlines worldwide. Now, for the first time, she offers specific recommendations based on her latest findings: who needs to be checked, where to be tested, and what to expect. Dr. Henschke and coauthor Peggy McCarthy, a leading patient advocate, provide up-to-the-minute information on diagnosis, treatment, and survival, accompanied by inspiring words from...

Lung Cancer Awareness Ribbon Magnet

Lung Cancer Awareness Ribbon Magnet
by Magnet Inc.

Model: M-LR-LUNG; Lung Cancer Awareness 2 in 1 Ribbon Magnet. High Quality UV protected printed vinyl ribbons backed with thick .30 mil magnetic material. Great fundraiser for awareness organizations, schools, churches, or your fundraiser group. Dimensions: 3 7/8" x 8"

© 2009 BrightSurf.com